{"id":61549,"date":"2025-07-09T04:06:52","date_gmt":"2025-07-09T02:06:52","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\/"},"modified":"2025-07-09T04:06:52","modified_gmt":"2025-07-09T02:06:52","slug":"preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\/","title":{"rendered":"Preceptis Medical Appoints Dave Carey as Chief Executive Officer to Lead Next Phase of Strategic Growth"},"content":{"rendered":"
\n

MINNEAPOLIS–(BUSINESS WIRE)–Preceptis Medical, Inc.<\/i>, a commercial-stage medical technology company transforming pediatric ENT care, today announced the appointment of Dave Carey <\/b>as Chief Executive Officer. Carey assumes leadership as the company accelerates toward full market release of its flagship product, the Hummingbird\u00ae<\/sup> Tympanostomy Tube System (TTS)<\/i>.<\/p>\n

<\/a>
<\/a><\/p>\n

\n\u201cWe are thrilled to welcome Dave Carey to Preceptis,\u201d said John Seaberg, Chairman of the Board at Preceptis Medical. \u201cHis deep industry expertise, strategic vision, and dedication to improving patient care make him the ideal leader to guide our next phase of growth.\u201d<\/p>\n

\nAs CEO, Carey will oversee the continued expansion of the Hummingbird TTS System in the U.S., which enables in-office pediatric ear tube placement without the need for general anesthesia. The device has already demonstrated significant clinical, economic, and patient satisfaction benefits in the company\u2019s limited market release.<\/p>\n

\n\u201cI\u2019m honored to join the Preceptis Medical team at such an important moment,\u201d said Dave Carey. \u201cHummingbird represents a true shift in how we approach pediatric ear tube procedures, and I look forward to partnering with our talented team and surgeon community to bring this solution to more families nationwide.\u201d<\/p>\n

\nPreceptis Medical\u2019s Hummingbird system enables in-office ear tube placement for young children without the need for general anesthesia, representing a safer, more cost-effective, and family-centered approach to care. For more information, visit www.preceptismedical.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nGreg Mielke
\n
Chief Commercial Officer
\n
Preceptis Medical, Inc.
\n
763.568.7810
\n
Greg@preceptismedical.com<\/b><\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MINNEAPOLIS–(BUSINESS WIRE)–Preceptis Medical, Inc., a commercial-stage medical technology company transforming pediatric ENT care, today announced the appointment of Dave Carey as Chief Executive Officer. Carey assumes leadership as the company accelerates toward full market release of its flagship product, the Hummingbird\u00ae Tympanostomy Tube System (TTS). \u201cWe are thrilled to welcome Dave Carey to Preceptis,\u201d said … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61549","6":"format-standard","7":"category-industry"},"yoast_head":"\nPreceptis Medical Appoints Dave Carey as Chief Executive Officer to Lead Next Phase of Strategic Growth - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Preceptis Medical Appoints Dave Carey as Chief Executive Officer to Lead Next Phase of Strategic Growth - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MINNEAPOLIS–(BUSINESS WIRE)–Preceptis Medical, Inc., a commercial-stage medical technology company transforming pediatric ENT care, today announced the appointment of Dave Carey as Chief Executive Officer. Carey assumes leadership as the company accelerates toward full market release of its flagship product, the Hummingbird\u00ae Tympanostomy Tube System (TTS). \u201cWe are thrilled to welcome Dave Carey to Preceptis,\u201d said ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-09T02:06:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250708823930\/en\/2518047\/22\/HUMMINGBIRD-TTS-Preceptis-144-Gray.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Preceptis Medical Appoints Dave Carey as Chief Executive Officer to Lead Next Phase of Strategic Growth\",\"datePublished\":\"2025-07-09T02:06:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\\\/\"},\"wordCount\":254,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250708823930\\\/en\\\/2518047\\\/22\\\/HUMMINGBIRD-TTS-Preceptis-144-Gray.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\\\/\",\"name\":\"Preceptis Medical Appoints Dave Carey as Chief Executive Officer to Lead Next Phase of Strategic Growth - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250708823930\\\/en\\\/2518047\\\/22\\\/HUMMINGBIRD-TTS-Preceptis-144-Gray.jpg\",\"datePublished\":\"2025-07-09T02:06:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250708823930\\\/en\\\/2518047\\\/22\\\/HUMMINGBIRD-TTS-Preceptis-144-Gray.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250708823930\\\/en\\\/2518047\\\/22\\\/HUMMINGBIRD-TTS-Preceptis-144-Gray.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Preceptis Medical Appoints Dave Carey as Chief Executive Officer to Lead Next Phase of Strategic Growth\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Preceptis Medical Appoints Dave Carey as Chief Executive Officer to Lead Next Phase of Strategic Growth - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\/","og_locale":"en_US","og_type":"article","og_title":"Preceptis Medical Appoints Dave Carey as Chief Executive Officer to Lead Next Phase of Strategic Growth - Pharma Trend","og_description":"MINNEAPOLIS–(BUSINESS WIRE)–Preceptis Medical, Inc., a commercial-stage medical technology company transforming pediatric ENT care, today announced the appointment of Dave Carey as Chief Executive Officer. Carey assumes leadership as the company accelerates toward full market release of its flagship product, the Hummingbird\u00ae Tympanostomy Tube System (TTS). \u201cWe are thrilled to welcome Dave Carey to Preceptis,\u201d said ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\/","og_site_name":"Pharma Trend","article_published_time":"2025-07-09T02:06:52+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250708823930\/en\/2518047\/22\/HUMMINGBIRD-TTS-Preceptis-144-Gray.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Preceptis Medical Appoints Dave Carey as Chief Executive Officer to Lead Next Phase of Strategic Growth","datePublished":"2025-07-09T02:06:52+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\/"},"wordCount":254,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250708823930\/en\/2518047\/22\/HUMMINGBIRD-TTS-Preceptis-144-Gray.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\/","url":"https:\/\/pharma-trend.com\/en\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\/","name":"Preceptis Medical Appoints Dave Carey as Chief Executive Officer to Lead Next Phase of Strategic Growth - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250708823930\/en\/2518047\/22\/HUMMINGBIRD-TTS-Preceptis-144-Gray.jpg","datePublished":"2025-07-09T02:06:52+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250708823930\/en\/2518047\/22\/HUMMINGBIRD-TTS-Preceptis-144-Gray.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250708823930\/en\/2518047\/22\/HUMMINGBIRD-TTS-Preceptis-144-Gray.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/preceptis-medical-appoints-dave-carey-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Preceptis Medical Appoints Dave Carey as Chief Executive Officer to Lead Next Phase of Strategic Growth"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61549","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61549"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61549\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61549"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61549"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61549"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}